Showing 40,661 - 40,680 results of 57,776 for search '(( 09 ((0 decrease) OR (a decrease)) ) OR ( 20 ((mm decrease) OR (we decrease)) ))', query time: 1.20s Refine Results
  1. 40661

    Roxadustat has risks of reversible central hypothyroidism in patients undergoing hemodialysis: a single-center retrospective cohort study by Emiko Otsuka (7519313)

    Published 2024
    “…Similarly, FT4 levels decreased from 1.11 (0.97–1.24) ng/dL before roxadustat treatment to 0.92 (0.71–1.03) ng/dL during treatment (<i>p</i> < 0.001) and improved to 1.05 (0.93–1.17) ng/dL after halting roxadustat (<i>p</i> < 0.001). …”
  2. 40662

    Table_4_The Effect of Dexmedetomidine on Emergence Agitation or Delirium in Children After Anesthesia—A Systematic Review and Meta-Analysis of Clinical Studies.DOC by Yuquan Rao (9118304)

    Published 2020
    “…The results showed that dexmedetomidine significantly decreased the incidence of post-anesthesia EA or ED compared with placebo [OR = 0.22, 95% CI: (0.16, 0.32), I<sup>2</sup> = 75, P < 0.00001], midazolam [OR = 0.36, 95% CI: (0.21, 0.63), I<sup>2</sup> = 57, P = 0.0003], and opioids [OR = 0.55, 95% CI: (0.33, 0.91), I<sup>2</sup> = 0, P = 0.02], whereas the significant difference was not exhibited compared with propofol (or pentobarbital) [OR = 0.56, 95% CI: (0.15, 2.14), I<sup>2</sup> = 58, P = 0.39], ketamine [OR = 0.43, 95% CI: (0.19, 1.00), I<sup>2</sup> = 0, P = 0.05], clonidine [OR = 0.54, 95% CI: (0.20, 1.45), P = 0.22], chloral hydrate [OR = 0.98, 95% CI: (0.26, 3.78), P = 0.98], melatonin [OR = 1.0, 95% CI: (0.13, 7.72), P = 1.00], and ketofol [OR = 0.55, 95% CI: (0.16, 1.93), P = 0.35].…”
  3. 40663
  4. 40664
  5. 40665
  6. 40666
  7. 40667
  8. 40668
  9. 40669
  10. 40670
  11. 40671
  12. 40672
  13. 40673
  14. 40674
  15. 40675
  16. 40676
  17. 40677
  18. 40678
  19. 40679
  20. 40680